Skip to main content
Can-Fite BioPharma Ltd. (TLV:CANF)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
646.30
-106.20 (-14.11%)
Mar 9, 2026, 5:24 PM IDT

Can-Fite BioPharma Revenue

Can-Fite BioPharma had revenue of $202.00K USD in the half year ending June 30, 2025, a decrease of -48.47%. This brings the company's revenue in the last twelve months to $560.00K, down -16.04% year-over-year. In the year 2024, Can-Fite BioPharma had annual revenue of $674.00K, down -9.29%.

Revenue (ttm)
$560.00K
Revenue Growth
-16.04%
P/S Ratio
10.44
Revenue / Employee
$112.00K
Employees
5
Market Cap
19.70M ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024674.00K-69.00K-9.29%
Dec 31, 2023743.00K-67.00K-8.27%
Dec 31, 2022810.00K-43.00K-5.04%
Dec 31, 2021853.00K90.00K11.80%
Dec 31, 2020763.00K-1.27M-62.45%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
XTL Biopharmaceuticals 3.26M
Evogene 26.54M
BioLight Life Sciences 21.00K
BioLineRx 42.17M
Clal Biotechnology Industries 91.00K
Geffen Residence & Renewal 84.00K
Revenue Rankings

Can-Fite BioPharma News

More News